Titan Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Four
Titan Pharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Four of $2.62 million as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2013-05-15
- 2012-12-31: Long-Term Debt, Maturity, Year Four $2.62M.
- 2011-11-14: Long-Term Debt, Maturity, Year Four $2.50M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2012-12-31 | $2.62M 10-K · filed 2013-03-18 |
| 2011-11-14 | $2.50M 10-Q · filed 2013-05-15 |